Form 4 Tracker
David Parrot

Chief Financial Officer · 1 filing · Latest: Mar 13, 2026

Scribe Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
SCTX
David ParrotChief Financial OfficerJul 23, 2026
Purchase
$15.002,666$40.0K1,333